Switch to हिंदी

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

हिंदी
  • Health A-Z
  • Diabetes
  • Diseases
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Cancer
    • Heart Attack
    • Pneumonia
    • Diseases A-Z
  • Diet & Fitness
    • Weight Management
    • Exercise & Body Building
    • Diet & Recipes
    • Yoga
  • Coronavirus
  • News
  • Pregnancy
    • Conceiving
    • Infertility
    • Labour & Delivery
    • Pregnancy week-by-week
    • Breastfeeding
    • Baby Names
  • Beauty
    • Skin
    • Hair
    • Grooming
  • Photos
  • Videos
Home / Health News / COVID-19 vaccine: Aurobindo Pharma Inks Pact With Covaxx to develop a vaccine for India

COVID-19 vaccine: Aurobindo Pharma Inks Pact With Covaxx to develop a vaccine for India

Aurobindo Pharma has joined hands with US-based company COVAXX to develop, commercialize and manufacture UB-612 for India.

By: Arushi Bidhuri   | | Published: December 24, 2020 4:50 pm
Tags: Coronavirus  Coronavirus Vaccine  COVID-19  
vaccine, coronavirus vaccine, COVID-19 vaccine, coronavirus treatment, COVID-19
कोवैक्सीन की दूसरी खुराक लेने को 1,000 वॉलंटियर तैयार

As COVID-19 continues in its surge, scientists are desperately trying to understand the virus and preparing for different vaccines to curb the disease to its curb. So far, there have been many positive developments bringing hope to the global population. India too is gearing up to battle coronavirus with homegrown vaccines like Biotech’s Covaxin. Also Read - Coronavirus vaccine: This nasal spray can block the virus for upto 2 days

Hyderabad-Based Firm And Covaxx To Develop COVID Vaccine

It has been reported that Aurobindo Pharma has joined hands with US-based company COVAXX to develop, commercialize and manufacture UB-612. The company has entered an exclusive license agreement to develop UB-612, the first Multitope Peptide-based vaccine to fight COVID-19, for India and the UN Children’s Fund (UNICEF) agency. Also Read - To vaccinate or not? Medical expert clears the air around Covid-19 vaccines



“We are proud to partner with COVAXX in developing the fire-ever synthetic peptide-based vaccine to combat the COVID-19 pandemic. This vaccine has immense potential in eliminating shedding, and hence containing, the spread of the pandemic,” said the Managing Director of Aurobindo Pharma Limited, N. Govindarajan, commented on the development. Also Read - Recovered from Covid-19? Your immune system may fight coronavirus variants

Currently, COVAXX is conducting a Phase I clinical trial for the vaccine candidate. As per the agreement, the Hyderabad-based firm has obtained the exclusive rights to develop, manufacture, and sell COVAXX’s UB-612 vaccine in India and to UNICEF, as well as non-exclusive rights in other select emerging and developing markets.

The Drug To Have A Total Capacity Of Nearly 480 Million Doses

Aurobindo has the capacity of manufacturing 220 million (22 crores) doses in multi-dose presentation and is building additional facilities to have a total capacity of nearly 480 million (48 crores) doses by June 2021.

“Covaxx is committed to providing an equitable distribution of UB-612 by prioritizing emerging markets where the unmet need is greatest,” said Mei Mei Hu, co-founder and CEO of COVAXX.

“During this global health crisis response, we must establish partners with the strongest capabilities, like Aurobindo, to prioritize the development and the delivery of our vaccine. As one of the leading industry players with a strong track record of execution and investment in vaccines, Aurobindo Pharma is the ideal partner to advance UB-612 in India and other emerging nations and to support our mission of democratizing health worldwide.”

Published : December 24, 2020 4:50 pm
Read Disclaimer

Covid-19 vaccine to be given to 51 lakh people in first phase in Delhi: Arvind Kejriwal

Covid-19 vaccine to be given to 51 lakh people in first phase in Delhi: Arvind Kejriwal

COVID-19 vaccine: Bharat Biotech’s Covaxin shows long-term antibodies

COVID-19 vaccine: Bharat Biotech’s Covaxin shows long-term antibodies

Please Wait. Article Loading ....

Coronavirus Updates

Coronavirus Updates

Stay Informed, Be Safe

  • Coronavirus vaccine: This nasal spray can block the virus for upto 2 days
  • To vaccinate or not? Medical expert clears the air around Covid-19 vaccines
  • Recovered from Covid-19? Your immune system may fight coronavirus variants
  • Covid-19 variant detected in UK may be ‘more deadly than the older virus strain’
  • UK COVID Strain May Be More Infectious But There Is No Need To Panic: Experts

Health Calculators

BMI Calculator
bmi Calculator
Ideal Body Weight
ideal body weight
Daily Calorie Intake
Daily calorie intake
Calories Burned
calories burned

Related Stories

Coronavirus vaccine: This nasal spray can block the virus for upto 2 days

Coronavirus vaccine: This nasal spray can block the virus for upto 2 days

To vaccinate or not? Medical expert clears the air around Covid-19 vaccines

To vaccinate or not? Medical expert clears the air around Covid-19 vaccines

Covid-19 vaccination: Concerns about adverse effects ‘unfounded, negligible’, says Govt

Covid-19 vaccination: Concerns about adverse effects ‘unfounded, negligible’, says Govt

'Game changer against Covid-19': Expert panel recommends phase 1 trial of Bharat Biotech's nasal vaccine

'Game changer against Covid-19': Expert panel recommends phase 1 trial of Bharat Biotech's nasal vaccine

‘Don’t take Covid-19 vaccine shot if...': Covaxin company warns people amid concerns

‘Don’t take Covid-19 vaccine shot if...': Covaxin company warns people amid concerns

Health News in Hindi

Weight Loss Diet: वेट लॉस के लिए एक्सपर्ट्स मानते हैं लो-फैट डायट को बेस्ट, जानें इस डायट के अन्य फायदे

बर्मिंघम यूनिवर्सिटी के शोधकर्ता बना रहे हैं एक ऐसा ‘नेजल स्प्रे’ जो 2 दिनों तक कोरोनावायरस को शरीर में जाने से रोकेगा

लालू प्रसाद यादव की तबीयत में सुधार नहीं, इस गंभीर संक्रमण से हैं ग्रस्त, दिल्ली के एम्स में चल रहा है इलाज

Covid-19 Symptoms: सूंघने की क्षमता कम होना है कोविड-19 का सबसे बड़ा लक्षण, नयी रिसर्च का दावा

Hand Sanitizer: सावधान! क्या आपका बच्चा भी यूज़ करता है हैंड सैनिटाइज़र? जा सकती है बच्चों की आंख की रोशनी, जानें कैसे

Read All

Recent Posts

  • Thyroid: Do you constantly feel exhausted? It could be a sign of Hypothyroidism
  • Coronavirus vaccine: This nasal spray can block the virus for upto 2 days
  • To vaccinate or not? Medical expert clears the air around Covid-19 vaccines
  • Egg freezing on rise in India: Is it the best choice to make? Know the pros and cons
  • Recovered from Covid-19? Your immune system may fight coronavirus variants

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com
+91 – 22 – 6697 1234
Landline Phone number 91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

Useful Links

  • Weight Loss
  • Keto Diet Tips
  • Skin Care Tips
  • Intermittent Fasting
  • Apple Cider Vinegar
  • Ashwagandha
  • Cancer
  • Pneumonia
  • Diarrhoea
  • Dengue
  • Typhoid
  • Tuberculosis
  • Chickenpox
  • Chikungunya
  • Depression
  • Hepatitis
  • Diabetes
  • Type 2 diabetes
  • Arthritis
  • Swine Flu
  • Baby Names
  • Cough and cold
  • Heart Attack
  • Breast Cancer
  • Ebola Virus
  • Dengue
  • Malaria
  • International Yoga Day
  • Hypotension
  • Heart Failure
  • Asthma
  • Brain Tumour
  • Celebrity Fitness
  • Goitre
  • HIV/AIDS

We respect your privacy

  • Disclaimer
  • Privacy Policy
  • Contact Us
  • Author Profiles

Copyright © 2021 Zee Entertainment Enterprises Limited. All rights reserved.